Fat-reducing composition as well as preparation method and application thereof

Through the combination of sea buckthorn leaf extract, rattan tea extract, Luohan fruit extract and coffee freeze-dried powder, a safe and effective fat-reducing composition is formed, which solves the problems of strong dependence and great side effects of existing weight loss products, and achieves the goal of achieving It has significantly improved fat loss and quality of life.

CN119033016AInactive Publication Date: 2024-11-29SHANGHAI TOUCHUANG NETWORK TECHNOLOGY CO LTD +1
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411370935.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-29
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing weight loss products have strong dependence, great side effects, and insufficient safety and effectiveness, making it difficult to meet the safe, effective and non-dependent fat loss needs of obese people.

Method used

The fat-reducing composition composed of sea buckthorn leaf extract, rattan tea extract, rhubarb extract and coffee freeze-dried powder was used to significantly reduce body weight, BMI, waist circumference, hip circumference and body fat rate through synergistic efficiency mechanism, and each group Safe and no side effects.

Benefits of technology

It significantly reduces weight, BMI, waist circumference, hip circumference and body fat rate, improves quality of life, and does not produce side effects caused by excessive caffeine, and is suitable for industrial applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention discloses a fat-reducing composition as well as a preparation method and application thereof. The fat-reducing composition comprises a hippophae rhamnoides leaf extract and a first mixed component and / or a second mixed component, wherein the first mixed component comprises an ampelopsis grossedentata extract and a fructus momordicae extract, the second mixed component comprises first coffee freeze-dried powder and second coffee freeze-dried powder, and the second coffee freeze-dried powder contains chlorogenic acid. The preparation method of the fat-reducing composition comprises the step of mixing all the components. All the components of the fat-reducing composition provided by the invention have a better fat-reducing effect through synergistic interaction, all the components belong to safe and side-effect-free components, dependence is not generated, and fat can be reduced more effectively.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of health food, and in particular to a fat-reducing composition and a preparation method and application thereof. Background Art

[0002] Obesity can generally be divided into two types: simple obesity and secondary obesity. Simple obesity refers to a condition in which the body's calorie intake is greater than its consumption, resulting in excessive fat accumulation in the body and abnormal weight. Simple obesity is the most common of all types of obesity, accounting for more than 95% of obesity.

[0003] The body mass index (BMI) is often calculated from height and weight to reflect systemic obesity: BMI = weight (kg) / height 2 (m 2 ). The "Guidelines for the Prevention and Control of Overweight and Obesity in Chinese Adults" stipulates that 18.5≤BMI<24 is normal; 24≤BMI<28 is overweight; ≥28 is obese.

[0004] According to the latest report "Diabetes, Obesity and Metabolism", in 2023, the proportion of overweight people in my country was 34.8%, and the proportion of obese people was 14.1%.

[0005] Obesity is not only an independent disease, but also a risk factor for type 2 diabetes, cardiovascular disease, hypertension, stroke and multiple cancers. It is one of the top ten risk factors for disease burden.

[0006] The existing weight loss products on the market are mainly drugs and health products. Drugs have a fat-reducing effect, but they are highly addictive, have serious side effects, and are prone to weight rebound after stopping the drug. Health products have a weak fat-reducing effect, and some products reduce weight by inducing diarrhea, which is harmful to health. They contain anthraquinone ingredients that have strong dependence and side effects.

[0007] Obese people are in urgent need of safe, effective and non-addictive fat-reducing products. Summary of the invention

[0008] The technical problem to be solved by the present invention is to provide a fat-reducing composition and a preparation method and application thereof, wherein the fat-reducing composition is safe, effective, and non-dependent, suitable for use in the preparation of fat-reducing products, and the preparation method of the fat-reducing composition is simple and convenient for industrial application.

[0009] To solve the above technical problems, the first aspect of the present invention is to provide a fat-reducing composition, comprising a seabuckthorn leaf extract; and

[0010] A first mixing component and / or a second mixing component;

[0011] The first mixed component includes rattan tea extract and monk fruit extract, the second mixed component includes a first freeze-dried coffee powder and a second freeze-dried coffee powder, and the second freeze-dried coffee powder contains chlorogenic acid.

[0012] In the fat-reducing composition provided by the present invention, seabuckthorn leaves are leaves of seabuckthorn, and seabuckthorn (Hippophae rhamnoides L.) belongs to the genus Hippophae of the family Elaeagnaceae. Seabuckthorn leaf extract mainly includes polyphenol compounds, which can reduce abdominal fat; rattan tea extract mainly includes flavonoid compounds such as dihydromyricetin, which can improve sugar and lipid metabolism and improve insulin resistance; Momordica grosvenori extract contains mogroside V, which can reduce weight and reduce fat, and has extremely high safety; chlorogenic acid in the second coffee freeze-dried powder can reduce lipid synthesis and down-regulate the expression of inflammatory factors, and also play a role in lowering blood sugar; the first coffee freeze-dried powder mainly plays the role of a carrier. In the fat-reducing composition formed by mixing seabuckthorn leaf extract with the first mixed component (rattan tea extract and momordica grosvenori extract), or seabuckthorn leaf extract with the second mixed component (the first coffee freeze-dried powder and the second coffee freeze-dried powder), or seabuckthorn leaf extract with the first mixed component and the second mixed component, each component has a synergistic fat-reducing effect, and each component in the present invention is a safe component without side effects, and does not produce dependence.

[0013] It should be noted that the caffeine content in the first freeze-dried coffee powder and the second freeze-dried coffee powder in the present invention may be the same or different. Preferably, the caffeine content in the first freeze-dried coffee powder is higher than that in the second freeze-dried coffee powder, so as to provide coffee aroma and taste. For example, the caffeine content in the first freeze-dried coffee powder may be 3.97wt%, and the caffeine content in the second freeze-dried coffee powder may be 2.07wt%. In addition, it should be noted that although studies have shown that caffeine can increase fat metabolism to a certain extent and reduce the content of free fatty acids and glycerol in the blood, its usage needs to reach 425mg / d and be combined with an energy-restricted diet to be effective. After the human body ingests a large amount of caffeine, it may cause side effects such as palpitations and headaches in people who are intolerant to caffeine. When the fat-reducing composition provided by the present invention is used as a fat-reducing product, the caffeine content in each serving of the fat-reducing product (daily dosage) is less than 80mg, so as to avoid adverse effects on people who are intolerant to caffeine.

[0014] Specifically, the fat-reducing composition includes, by weight:

[0015] 2-12 parts by weight or 2 parts by weight or 8 parts by weight or 12 parts by weight, preferably 8 parts by weight, of seabuckthorn leaf extract, wherein the content of polyphenol compounds is not less than 20wt% or not less than 25wt%, preferably not less than 25wt%;

[0016] 1-13 parts by weight or 1 part by weight or 4 parts by weight or 13 parts by weight, preferably 4 parts by weight, of an extract of Ampelopsis ulmoides L., wherein the dihydromyricetin content is not less than 30 wt% or not less than 40 wt%, preferably not less than 40 wt%;

[0017] The monk fruit extract is 1-4 parts by weight or 1 part by weight or 3 parts by weight or 4 parts by weight, preferably 4 parts by weight, and its mogroside V content is not less than 1wt% or not less than 1.5wt%, preferably not less than 1.5wt%.

[0018] Specifically, the fat-reducing composition includes, by weight:

[0019] 2-12 parts by weight or 2 parts by weight or 8 parts by weight or 12 parts by weight, preferably 8 parts by weight, of seabuckthorn leaf extract, wherein the content of polyphenol compounds is not less than 20wt% or not less than 25wt%, preferably not less than 25wt%;

[0020] 9 to 33 parts by mass, or 9 parts by mass, or 26 parts by mass, or 33 parts by mass, preferably 26 parts by mass, of first freeze-dried coffee powder;

[0021] The second freeze-dried coffee powder comprises 11 to 35 parts by mass or 11 parts by mass or 18 parts by mass or 35 parts by mass, preferably 18 parts by mass, and its chlorogenic acid content is 10wt% to 15wt% or 10wt% to 12wt% or 12wt% to 15wt% or 12wt%, preferably 12wt%.

[0022] Specifically, the fat-reducing composition includes, by weight:

[0023] 2-12 parts by weight or 2 parts by weight or 8 parts by weight or 12 parts by weight, preferably 8 parts by weight, of seabuckthorn leaf extract, wherein the content of polyphenol compounds is not less than 20wt% or not less than 25wt%, preferably not less than 25wt%;

[0024] 1-13 parts by weight or 1 part by weight or 4 parts by weight or 13 parts by weight, preferably 4 parts by weight, of an extract of Ampelopsis ulmoides L., wherein the dihydromyricetin content is not less than 30 wt% or not less than 40 wt%, preferably not less than 40 wt%;

[0025] 1-4 parts by weight or 1 part by weight or 3 parts by weight or 4 parts by weight, preferably 4 parts by weight, of a monk fruit extract, wherein the content of mogroside V is not less than 1wt% or not less than 1.5wt%, preferably not less than 1.5wt%;

[0026] 9 to 33 parts by mass, or 9 parts by mass, or 26 parts by mass, or 33 parts by mass, preferably 26 parts by mass, of first freeze-dried coffee powder;

[0027] The second freeze-dried coffee powder comprises 11 to 35 parts by mass or 11 parts by mass or 18 parts by mass or 35 parts by mass, preferably 18 parts by mass, and its chlorogenic acid content is 10wt% to 15wt% or 10wt% to 12wt% or 12wt% to 15wt% or 12wt%, preferably 12wt%.

[0028] In the present invention, when the components in the fat-reducing composition are in preferred weight parts, the synergistic effect between the components is most obvious, which can significantly reduce body weight, BMI, waist circumference, hip circumference and body fat percentage (P < 0.05), subcutaneous fat thickness (P < 0.05), SF-36 score significantly increased by 2.53% (P < 0.05), and ZWQOL score significantly decreased by 17.86% (P < 0.01).

[0029] In order to solve the above technical problems, the second aspect of the present invention is to provide a use of the aforementioned fat-reducing composition in the preparation of fat-reducing products. It is understandable that, because the fat-reducing compositions provided by the present invention have synergistic effects, they have significant effects of reducing body weight, BMI, waist circumference, hip circumference and body fat rate (P < 0.05), subcutaneous fat thickness (P < 0.05), etc., and the SF-36 score is significantly increased by 2.53% (P < 0.05), and the ZWQOL score is significantly reduced by 17.86% (P < 0.01). Therefore, the fat-reducing products prepared after the fat-reducing products are applied to the preparation of fat-reducing products have at least all the beneficial effects of the fat-reducing composition. It should be noted that the fat-reducing products in the present invention include oral liquids, granules, powders, capsules or tablets.

[0030] In order to solve the above technical problems, the third aspect of the present invention is to provide a method for preparing the aforementioned fat-reducing composition, wherein the preparation method is to uniformly mix the components of the fat-reducing composition to obtain the fat-reducing composition. For example, firstly, the rattan tea extract and the monk fruit extract are powdered and mixed in a desired proportion to obtain a first mixed component, then the first coffee freeze-dried powder and the second coffee freeze-dried powder are powdered and mixed in a desired proportion to obtain a second mixed component, and finally, the seabuckthorn leaf extract is powdered and mixed with the first mixed component and / or the second mixed component in a desired proportion as required; in the present invention, the mixing can be stirred and mixed in a mixing tank, for example.

[0031] In the present invention, the method for preparing the seabuckthorn leaf extract comprises extracting the seabuckthorn leaf extract from the seabuckthorn leaf with water as a solvent, and then obtaining the powdered seabuckthorn leaf extract by spray drying; specifically, for example, the seabuckthorn leaf is first crushed and passed through a 30-mesh sieve (or a 40-mesh sieve), and then pure water of 10 to 20 times the mass of the seabuckthorn leaf powder is added, heated to 70 to 95° C. and stirred for 30 to 100 minutes, the effluent is passed through a 50 to 200-mesh sieve, and then centrifuged at a speed of 2000 to 5000 rpm for 2 to 20 minutes, and a clarified extract is obtained, and the clarified extract is concentrated at 20 to 80° C. and a pressure of 40 to 70 mbar to a Brix of 9 to 12%, and the concentrated extract is spray dried at an inlet temperature of 155 to 185° C. and an outlet temperature of 80 to 90° C. to obtain a powdered seabuckthorn leaf extract.

[0032] In the present invention, the first freeze-dried coffee powder and the powdered second freeze-dried coffee powder can be obtained, for example, by the following method: purchasing the commercially available first freeze-dried coffee powder and the second freeze-dried coffee powder, mixing them in a desired ratio and then crushing them, passing them through a 30-mesh sieve (or a 40-mesh sieve) to reduce the original particle size for easy mixing. Preferably, the seabuckthorn leaf extract, the rattan tea extract, the monk fruit extract, the first freeze-dried coffee powder and the second freeze-dried coffee powder are all powders.

[0033] In the present invention, the rattan tea extract and the powdered monk fruit extract are both commercially available, or can be used after being sieved through a 30-mesh sieve (or a 40-mesh sieve).

[0034] The fat-reducing composition of the present invention is intended to be mixed uniformly, and the order of adding the materials during stirring does not constitute a limitation to the present invention. The method for preparing the fat-reducing composition of the present invention is simple to operate and is convenient for large-scale and industrial applications. DETAILED DESCRIPTION

[0035] The technical solution of the present invention will be described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0036] Example 1 Preparation of fat-reducing composition

[0037] 1. Material preparation

[0038] 1) Preparation of Powdered Seabuckthorn Leaf Extract

[0039] Seabuckthorn leaf pretreatment: crush the seabuckthorn leaves and pass through a 30-mesh sieve for later use;

[0040] Extraction: Add 14 times the mass of water to the crushed seabuckthorn leaves, heat to 95°C, stir for 60 minutes, and pass the liquid through an 80-mesh sieve to obtain the extract;

[0041] Centrifugation: Centrifuge the extract at 4000 rpm for 5 min, and take the clarified solution for later use;

[0042] Concentration: Concentrate at 55°C and 50 mbar until Brix reaches 10% to obtain a concentrated solution;

[0043] Spray drying: the concentrated liquid is added into the spray drying equipment, the inlet temperature is set to 175°C, the outlet temperature is set to 80°C, and the powdered seabuckthorn leaf extract is obtained by spray drying.

[0044] 2) Powdered rattan tea extract (with a dihydromyricetin content of 40 wt%) and powdered monk fruit extract (with a mogroside V content of 1.5 wt%) were purchased from Hualuyuan Biotechnology Co., Ltd. and can be used directly.

[0045] 3) Preparation of a powdered mixture of the first freeze-dried coffee powder and the second freeze-dried coffee powder

[0046] The first coffee freeze-dried powder and the second coffee freeze-dried powder were purchased from Sheka Group, wherein the chlorogenic acid content of the second coffee freeze-dried powder was 12wt%. The first coffee freeze-dried powder and the second coffee freeze-dried powder were mixed in proportion, then added into a grinder and crushed, and passed through a 40-mesh sieve to obtain a powdery mixture of the first coffee freeze-dried powder and the second coffee freeze-dried powder.

[0047] 2. Preparation of fat-reducing composition

[0048] 1) Add the prepared seabuckthorn leaf extract, rattan tea extract and monk fruit extract into a mixing tank according to proportion and stir for 30 minutes.

[0049] 2) The powdered mixture of the first freeze-dried coffee powder and the second freeze-dried coffee powder is placed in the mixing tank of step 1) and stirred for 30 minutes. After metal detection, the mixture is discharged for use.

[0050] The addition amount of each component of the sample prepared in this example is shown in Table 1.

[0051] Table 1

[0052]

[0053] Example 2 Evaluation of the efficacy of the fat-reducing composition on mice

[0054] Experimental animals: 6-week-old male C57BL / 6J mice;

[0055] Experimental method: Mice were given a high-fat diet of D12492 with 60 kcal% fat. After four weeks of high-fat modeling, mice with significant weight gain were selected and randomly divided into 13 groups, with 8 mice in each group, which were used as the model group, experimental groups 1-5 and control groups 1-7 respectively; during this period, another 8 mice were selected and given a maintenance diet (without high-fat modeling) as the blank group. Afterwards, 14 groups of mice were fed normally for 8 weeks, wherein the mice in experimental groups 3-5 were respectively given 455 mg / kg of the fat-reducing composition of experimental groups 3-5 in Example 1 per day, the mice in experimental group 1 were given 394 mg / kg of the mixture of experimental group 1 in Example 1, the mice in experimental group 2 were given 121 mg / kg of the mixture of experimental group 2 in Example 1, the mice in control group 1 were given 61 mg / kg of the seabuckthorn leaf extract of control group 1 in Example 1 per day, the mice in control group 2 were given 30 mg / kg of the rattan tea extract of control group 2 in Example 1 per day, the mice in control group 3 were given 30 mg / kg of the monk fruit extract of control group 3 in Example 1 per day, the mice in control group 4 were given 334 mg / kg of the mixture of control group 4 in Example 1 per day, the mice in control group 5 were given 364 mg / kg of the mixture of control group 5 in Example 1, the mice in control group 6 were given 364 mg / kg of the mixture of control group 6 in Example 1, and the mice in control group 7 were given 61 mg / kg of the mixture of control group 7 in Example 1. The model group and the blank group were given an equal amount of the corresponding solvent (in this embodiment, the solvents in the experimental group and the control group were both normal saline. During feeding, the required amount of solid powder was easily dissolved in normal saline and then provided to the mice for drinking). During the feeding period, body weight was measured every week; after the feeding, the liver weight, abdominal fat weight, and subcutaneous fat weight were measured, and fasting blood sugar and insulin were tested, the HOMA-IR index was calculated, and the activities of fatty acid synthase FAS and carnitine palmitoyltransferase (CPT) in the liver were tested.

[0056] Among them, HOMA-IR index = fasting blood glucose level (mmol / L) × fasting insulin level (mIU / L) / 22.5; insulin unit conversion is: 1ng / ml×21.2=μIU / ml (mIU / L);

[0057] In this embodiment, the synergistic effect q is calculated according to King's formula:

[0058] q=E(A+B) / (EA+EB-EA*EB)

[0059] In the formula, EA and EB are the effects of A and B acting alone, E(A+B) is the effect of their combined use, q value is 0.85-1.15 for simple addition, q value is 1.15-20 for enhancement, q value is greater than 20 for obvious enhancement, q value is 0.56-0.85 for antagonism, and q value is less than 0.55 for obvious antagonism.

[0060] In this embodiment, for example, the use of the mixture of seabuckthorn leaf extract, rattan tea extract and monk fruit extract is defined as EA alone, the use of the mixture of the first coffee freeze-dried powder and the second coffee freeze-dried powder is defined as EB alone, and the use of the fat-reducing composition formed by mixing the extract, rattan tea extract, monk fruit extract, the first coffee freeze-dried powder and the second coffee freeze-dried powder is defined as E(A+B) in combination.

[0061] Test Results

[0062] 1) The test results of the weight changes of mice in each group are shown in Table 2-1 and Table 2-2, and the weight loss synergy between the groups is shown in Table 3:

[0063] Table 2-1

[0064]

[0065] Table 2-2

[0066]

[0067]

[0068] In Tables 2-1 and 2-2, # indicates P < 0.05 compared with the blank group, ## indicates P < 0.01 compared with the blank group, * indicates P < 0.05 compared with the model group, and ** indicates P < 0.01 compared with the model group.

[0069] Table 3

[0070]

[0071] In Table 3, the numbers marked with * indicate P < 0.05 compared with the model group, and the numbers marked with ** indicate P < 0.01 compared with the model group.

[0072] From Tables 2-1 and 2-2, it can be seen that there was no significant difference in the initial body weight of mice in each group (P < 0.05). Starting from the first week, compared with the model group, the body weight of mice in experimental groups 3 to 5 decreased significantly (P < 0.05), among which the mice in experimental group 5 lost the most weight. At the eighth week, the body weight of mice in experimental group 5 decreased by 21.5%; while the control group 1, experimental group 1 and experimental group 2 began to show weight loss effects from the third week; and the other control groups did not show weight loss effects.

[0073] Experimental group 5 is equivalent to the combination of control group 4 and experimental group 2 or experimental group 1 and control group 7. The q values ​​calculated by King's formula are 1.36 and 1.40, respectively, which belong to the effect enhancement level, see Table 3 for details. Experimental group 1 consists of control groups 1 and 4, with a q value of 1.11. Sea buckthorn leaf extract powder is combined with coffee mixed powder, and the weight loss effect is only a simple addition. Control group 5 consists of control groups 2 and 4, and control group 6 consists of control groups 3 and 4. The above rattan tea extract powder and monk fruit extract powder are used alone with coffee mixed powder, and there is no improvement in efficacy. Control group 7 consists of control groups 2 and 3, and the combination of rattan tea and monk fruit also does not show an improvement in efficacy. Experimental group 2 consists of control groups 1 and 7, with a q value of 1.16. The combination of sea buckthorn leaf extract, rattan tea extract and monk fruit extract has a synergistic effect of inhibiting weight gain.

[0074] From the weight measurement of each group of mice, it can also be seen that the combination of seabuckthorn leaf extract, rattan tea extract and monk fruit extract has a synergistic weight loss effect, or the synergistic weight loss effect of the combination of seabuckthorn leaf extract, rattan tea extract and monk fruit extract, the first coffee freeze-dried powder and the second coffee freeze-dried powder is further enhanced, which is better than the mixture of seabuckthorn leaf extract, rattan tea extract and monk fruit extract used alone, or better than the mixture of the first coffee freeze-dried powder and the second coffee freeze-dried powder used alone, or better than seabuckthorn leaf extract used alone, or better than rattan tea extract used alone, or better than monk fruit extract used alone.

[0075] 2) The measurement results of liver weight, abdominal fat weight and subcutaneous fat weight of mice in each group are shown in Table 4:

[0076] Table 4

[0077]

[0078] In Table 4, # indicates P < 0.05 compared with the blank group, ## indicates P < 0.01 compared with the blank group, * indicates P < 0.05 compared with the model group, and ** indicates P < 0.01 compared with the model group.

[0079] As can be seen from Table 4, compared with the blank group, the abdominal fat weight and subcutaneous fat weight of the model group mice were significantly increased (P < 0.01). Compared with the model group, experimental groups 1-5 were able to significantly reduce liver weight (P less than 0.05). Experimental groups 1 to 5 and control group 1 were able to reduce abdominal fat weight and subcutaneous fat weight (P < 0.05). Experimental group 5 had a better effect on reducing abdominal fat and subcutaneous fat. The other control groups had no significant effect on reducing liver, abdominal fat and subcutaneous fat weight (P > 0.05).

[0080] Through the calculation of the synergy coefficient, the calculation results of abdominal fat and subcutaneous fat are shown in Table 5 and Table 6 respectively:

[0081] Table 5

[0082]

[0083] Table 6

[0084]

[0085]

[0086] In Tables 5 and 6, # indicates P < 0.05 compared with the blank group, ## indicates P < 0.01 compared with the blank group, * indicates P < 0.05 compared with the model group, and ** indicates P < 0.01 compared with the model group.

[0087] As can be seen from Table 5, for reducing abdominal fat, experimental group 5 is equivalent to the combination of control group 4 and experimental group 2 or the combination of experimental group 1 and control group 7. The q values ​​calculated by King's formula are 1.44 and 1.49, respectively, which belong to the effect enhancement level, indicating that the above combination can synergistically inhibit the increase of abdominal fat. Experimental group 1 consists of control groups 1 and 4, with a q value of 1.10. The sea buckthorn leaf extract powder is combined with the coffee mixed powder, and the weight loss effect is only a simple addition. Comparative group 5 consists of control groups 2 and 4, and control group 6 consists of control groups 3 and 4. The above rattan tea extract powder or monk fruit extract powder is used in combination with the coffee mixed powder, respectively, and there is no improvement in efficacy. Comparative group 7 consists of control groups 2 and 3, with a q value of 1.22. The combination of rattan tea and monk fruit can synergistically inhibit abdominal fat. Experimental group 2 consists of control groups 1 and 7, with a q value of 1.17. The combination of sea buckthorn leaf extract, rattan tea extract and monk fruit extract has a synergistic effect of inhibiting the increase of abdominal fat.

[0088] As can be seen from Table 6, for reducing subcutaneous fat, experimental group 5 is equivalent to the combination of control group 4 and experimental group 2 or the combination of experimental group 1 and control group 7. The q values ​​calculated by Jin's formula are 1.78 and 1.80 respectively, which belong to the effect enhancement level, indicating that the above combination can synergistically inhibit the increase of subcutaneous fat. Experimental group 1 is composed of control groups 1 and 4, with a q value of 1.28. The combination of seabuckthorn leaf extract powder and coffee mixed powder can also synergistically increase the subcutaneous fat inhibition effect. Control group 5 is composed of control groups 2 and 4, and control group 6 is composed of control groups 3 and 4. The above rattan tea extract powder and monk fruit extract powder are used in combination with coffee mixed powder, respectively, and there is no improvement in efficacy. Control group 7 is composed of control groups 2 and 3, with a q value of 1.01. The mixed powder of rattan tea and monk fruit is only a simple addition of efficacy. Experimental group 2 is composed of control groups 1 and 7, with a q value of 1.31. The combination of seabuckthorn leaf extract, rattan tea extract and monk fruit extract has the effect of synergistically inhibiting the increase of subcutaneous fat.

[0089] It can be seen from Tables 5 to 6 that the combined use of the seabuckthorn leaf extract, rattan tea extract and monk fruit extract provided by the present invention is better than the use of the seabuckthorn leaf extract, rattan tea extract and monk fruit extract alone. The combined use of the seabuckthorn leaf extract, rattan tea extract and monk fruit extract, the first coffee freeze-dried powder and the second coffee freeze-dried powder is better than the mixed use of the seabuckthorn leaf extract, rattan tea extract and monk fruit extract, and is also better than the mixed use of the first coffee freeze-dried powder and the second coffee freeze-dried powder. The fat-reducing composition of the present invention produces a synergistic enhancement effect, among which the effect of experimental group 5 is better.

[0090] In addition, it can be seen that the combination of seabuckthorn leaf extract powder and coffee mixed powder can also synergistically increase the subcutaneous fat suppression effect. This synergistic effect was not observed in the combination of rattan tea extract, monk fruit extract and coffee powder.

[0091] 3) Effects of fasting blood glucose, insulin and HOMA-IR in each group of mice As shown in Table 8:

[0092] Table 8

[0093]

[0094] In Table 7, # indicates P < 0.05 compared with the blank group, ## indicates P < 0.01 compared with the blank group, * indicates P < 0.05 compared with the model group, and ** indicates P < 0.01 compared with the model group.

[0095] It can be seen from Table 7 that compared with the blank group, the fasting blood glucose FBG, insulin, and HOMA-IR index of the model group were significantly increased (P < 0.01). Compared with the model group, experimental groups 2, 3, 5 and comparison group 1 were able to significantly reduce fasting blood glucose FBG (P < 0.05). Experimental groups 2 to 5, and comparison group 1 were able to significantly reduce insulin levels and HOMA-IR index (P < 0.05). Experimental group 5 had the best effect in reducing fasting blood glucose. The results showed that comparison group 4 had no significant improvement on fasting blood glucose, insulin, and HOMA-IR in mice. After consuming the fat-reducing composition provided by the present invention, it showed a significant effect of reducing blood sugar and alleviating insulin resistance.

[0096] 4) Effects on the activities of fatty acid synthase FAS and carnitine palmitoyltransferase (CPT) in the liver of mice in each group As shown in Table 8:

[0097] Table 8

[0098]

[0099]

[0100] In Table 8, # indicates P < 0.05 compared with the blank group, ## indicates P < 0.01 compared with the blank group, * indicates P < 0.05 compared with the model group, and ** indicates P < 0.01 compared with the model group.

[0101] As can be seen from Table 8, compared with the blank group, the CPT-1 activity of the model group was significantly reduced (P < 0.01), indicating that the high-fat diet impairs lipid transport and metabolic capacity. Compared with the model group, experimental groups 1 to 5 and comparative example 1 were able to significantly increase CPT-1 activity (P < 0.05), indicating that the seabuckthorn leaf extract, the mixture of the seabuckthorn leaf extract and coffee powder, the mixture of the seabuckthorn leaf extract, the vine tea extract and the monk fruit extract, and the fat-reducing composition of the present invention are able to increase the entry of fatty acyl CoA into mitochondria and promote fatty acid β-oxidation.

[0102] Table 8 shows that compared with the blank group, the FAS activity in the model group increased significantly (P < 0.01), indicating that the activity of lipid synthase FAS in the liver increased under the induction of a high-fat diet, promoting the synthesis of fat. Compared with the model group, the FAS activity in experimental group 5 was significantly reduced (P < 0.05). There was no significant effect in experimental groups 1-4 and control groups 1 to 7. This suggests that the fat-reducing composition in experimental group 5 can reduce the synthesis of fat by reducing FAS activity.

[0103] It can be seen from this example that the fat-reducing composition provided by the present invention can significantly reduce the accumulation of fat in the liver, subcutaneous tissue and abdomen, reduce fat volume, and can reduce fat synthesis (FAS), promote fatty acid transport and β-oxidation (CPT-1) to decompose fat, alleviate insulin resistance, and show excellent fat-reducing and weight-reducing effects.

[0104] Example 3 Evaluation of the efficacy of the fat-reducing composition of experimental group 5 in human food trial

[0105] 1) Baseline information of subjects

[0106] Table 9 shows that there were 30 participants (7 males and 23 females) with a mean age of 38.73±7.21 years and a mean BMI of 23.54±3.67 kg / m 2 The subjects were overweight or not overweight but dissatisfied with their weight and body shape.

[0107] Table 9

[0108]

[0109] 2) Effect of the fat-reducing composition of experimental group 5 on the weight and BMI of the subjects

[0110] Table 10 shows the effects of the fat-reducing composition of experimental group 5 on the body weight and BMI of the subjects:

[0111] Table 10

[0112]

[0113] In Table 10, # indicates P < 0.05 compared with before taking; ## indicates P < 0.01 compared with before taking; * indicates P < 0.05 compared with the first month of taking; ** indicates P < 0.01 compared with the first month of taking;

[0114] As can be seen from Table 10, compared with the weight before taking, the weight and BMI values ​​of the experimental group 5 were significantly reduced after taking the fat-reducing composition for one and two months (p<0.05). The change value was obtained by subtracting the value after taking the composition from the value before taking the composition. Compared with the change value in the first month, the change in the second month increased significantly. The weight in the second month decreased significantly by (1.11±1.33) kg (p<0.05), a decrease of 1.71%, and the BMI value decreased significantly by (0.34±0.47) kg / m 2 (p<0.05), a decrease of 1.45%.

[0115] 3) Effects of the fat-reducing composition of experimental group 5 on waist circumference, hip circumference and waist-to-hip ratio (WHR) of subjects

[0116] Table 11 shows the effects of the fat-reducing composition of experimental group 5 on the waist circumference, hip circumference and waist-to-hip ratio (WHR) of the subjects:

[0117] Table 11

[0118]

[0119] In Table 11, # indicates P < 0.05 compared with before taking the medicine; ## indicates P < 0.01 compared with before taking the medicine; * indicates P < 0.05 compared with the first month of taking the medicine; ** indicates P < 0.01 compared with the first month of taking the medicine.

[0120] As can be seen from Table 11, compared with the circumference before taking, the waist circumference, hip circumference, and WHR values ​​of the experimental group 5 were significantly reduced after taking the fat-reducing composition for one and two months (p<0.05). The change value was obtained by subtracting the value after taking from the value before taking. Compared with the value reduced in the first month, the reduction in the second month was greater. There was no statistical difference in the above data. The waist circumference decreased by 2.16% in the first month and 2.35% in the second month. It may be because the reduction in the first month was greater, so compared with the change value in the first month, there was no significant difference in the change in the second month.

[0121] 4) Effect of the fat-reducing composition of experimental group 5 on the body fat percentage of the subjects

[0122] Table 12 shows the effect of the fat-reducing composition of experimental group 5 on the body fat percentage of the subjects

[0123] Table 12

[0124]

[0125] In Table 12, # indicates P < 0.05 compared with before taking the medicine; ## indicates P < 0.01 compared with before taking the medicine; * indicates P < 0.05 compared with the first month of taking the medicine; ** indicates P < 0.01 compared with the first month of taking the medicine.

[0126] Table 12 shows that compared with the weight before taking the fat-reducing composition, the body fat percentage of experimental group 5 was significantly reduced after taking the fat-reducing composition for one and two months (p<0.05), but there was no statistical difference. The body fat percentage decreased by 3.71% in the first month. Compared with the change value in the first month, the body fat percentage in the second month decreased significantly by (2.12±2.27)% (p<0.05), a decrease of 6.34%, and the body fat percentage decreased faster in the second month.

[0127] 5) Effect of the fat-reducing composition of experimental group 5 on the thickness of subcutaneous fat of subjects

[0128] Table 13 shows the effect of the fat-reducing composition of experimental group 5 on the subcutaneous fat thickness of subjects at four points A, B, C, and D (point A is the midpoint of the outer side of the arm at the lower edge of the right deltoid muscle, point B is the lower angle of the right scapula, point C is 3 cm beside the right umbilicus, and point D is the right anterior superior iliac spine):

[0129] Table 13

[0130]

[0131] In Table 13, # indicates P < 0.05 compared with before taking the medicine; ## indicates P < 0.01 compared with before taking the medicine; * indicates P < 0.05 compared with the first month of taking the medicine; ** indicates P < 0.01 compared with the first month of taking the medicine.

[0132] As can be seen from Table 13, the thickness of subcutaneous fat at points A, B, C, and D was significantly reduced compared to before taking the fat-reducing composition of experimental group 5 for one month (P < 0.05). After taking the fat-reducing composition of experimental group 5 for two months, the thickness of subcutaneous fat at points A, B, C, and D was significantly reduced (P < 0.05), of which point D was reduced by 16.57% (P < 0.05). Example 3 can reduce the thickness of subcutaneous fat at various parts of the body. Point D was reduced by 16.57% (P < 0.05), which shows that Example 3 has a more significant reduction in the thickness of subcutaneous fat at the anterior superior iliac spine of point D.

[0133] Compared with the change value in the first month, the change value of point A at the lower edge of the deltoid muscle of the right arm in the second month was significantly reduced by (2.04±3.15) cm (p<0.05), a decrease of 10.23%. The growth rate of subcutaneous fat thickness was reduced in the second month.

[0134] 6) Effect of the fat-reducing composition of experimental group 5 on the quality of life of the subjects

[0135] Table 14 shows the effect of the fat-reducing composition of experimental group 5 on the quality of life of the subjects, and Table 15 shows the SF-36 score results:

[0136] Table 14

[0137]

[0138] Table 15

[0139]

[0140] In Tables 14 and 15, # indicates P < 0.05 compared with the results before administration; ## indicates P < 0.01 compared with the results before administration.

[0141] As can be seen from Table 14, compared with before taking, the ZWQOL score and SF-36 score of the experimental group 5 showed an improvement trend one month after taking the fat-reducing composition. After taking it for two months, the SF-36 score increased significantly by 2.53% (p<0.05), and the ZWQOL score decreased significantly by 17.86% (p<0.01). The results show that after taking it for two months, the composition can improve the quality of life of the subjects and reduce the impact of weight on the quality of life.

[0142] Table 15 shows that compared with before taking, the physiological function (RP) and general health status (GH) in the SF-36 score can be significantly improved one month after taking the fat-reducing composition of test group 3 (p<0.05). After taking it for two months, the physiological function (PF), general health status (GH) and health change (HT) in the SF-36 score all increased significantly (p<0.05). Among them, the physiological function (PF) and health change (HT) have shown an improvement trend one month after taking it, and showed a significant increase in the second month.

[0143] It can be seen from this example that the fat-reducing composition provided by the present invention can effectively reduce body weight, BMI, waist circumference, hip circumference, and reduce body fat percentage and subcutaneous fat thickness, thereby improving the quality of life of the subjects.

[0144] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.

Claims

1. A fat-reducing composition, characterized in that: including sea buckthorn leaf extract; and A first mixing component and / or a second mixing component; The first mixed component includes rattan tea extract and monk fruit extract, the second mixed component includes a first freeze-dried coffee powder and a second freeze-dried coffee powder, and the second freeze-dried coffee powder contains chlorogenic acid.

2. The fat-reducing composition according to claim 1, characterized in that The fat-reducing composition comprises, by weight: 2-12 parts by weight of seabuckthorn leaf extract; 1-13 parts by weight of rattan tea extract; 1 to 4 parts by weight of Momordica grosvenori extract.

3. The fat-reducing composition according to claim 1, characterized in that The fat-reducing composition comprises, by weight: 2-12 parts by weight of seabuckthorn leaf extract; 9 to 33 parts by weight of first freeze-dried coffee powder; 11 to 35 parts by weight of the second freeze-dried coffee powder.

4. The fat-reducing composition according to claim 1, characterized in that: The fat-reducing composition comprises, by weight: 2-12 parts by weight of seabuckthorn leaf extract; 1-13 parts by weight of rattan tea extract; 1-4 parts by weight of monk fruit extract; 9 to 33 parts by weight of first freeze-dried coffee powder; 11 to 35 parts by weight of the second freeze-dried coffee powder.

5. The fat reducing composition according to any one of claims 1 to 4, characterized in that: The polyphenol content of 2 parts by weight, 8 parts by weight, or 12 parts by weight of the seabuckthorn leaf extract is not less than 20 wt% or not less than 25 wt%.

6. The fat reducing composition according to any one of claims 1, 2 or 4, characterized in that: 1 part by weight, 4 parts by weight, or 13 parts by weight of the rattan tea extract, wherein the content of dihydromyricetin is not less than 30 wt % or not less than 40 wt %; The content of mogroside V in 1 part by weight, 3 parts by weight, or 4 parts by weight of the monk fruit extract is not less than 1 wt % or not less than 1.5 wt %.

7. The fat reducing composition according to any one of claims 1, 3 or 4, characterized in that: 9 parts by mass, 26 parts by mass, or 33 parts by mass of the first freeze-dried coffee powder; The content of chlorogenic acid in 11 parts by mass, 18 parts by mass, or 35 parts by mass of the second freeze-dried coffee powder is 10wt% to 15wt%, 10wt% to 12wt%, 12wt% to 15wt%, or 12wt%.

8. Use of the fat-reducing composition according to any one of claims 1 to 4 in the preparation of a fat-reducing product.

9. The use according to claim 4, characterized in that The fat-reducing product includes oral liquid, granules, powder, capsule or tablet.

10. A method for preparing the fat-reducing composition according to any one of claims 1 to 4, characterized in that: The fat-reducing composition is obtained by uniformly mixing the components of the fat-reducing composition.

Citation Information

Cited By

  • Fat-reducing composition as well as preparation method and application thereof

    CN120267028A

  • A fat-reducing composition and its preparation method and application

    CN120267028B